Cell survival during T-cell development is a carefully controlled process. Early in development, signals through the pre-T-cell receptor (pre-TCR, composed of TCRb and pTa) promote proliferation, survival, and differentiation of immature (CD4ÀCD8À) progenitors. Further rearrangement of the a chain of the TCR completes the assembly of the T-cell antigen receptor, and thymocytes are then subjected to stringent selection based on its specificity. Cells bearing a TCR with low affinity for self-peptide bound to a self-MHC molecule receive a survival signal and undergo continued differentiation, a process termed as positive selection. Thymocytes with receptors that have high affinity for selfpeptide MHC complexes undergo apoptosis in a process called negative selection, whereas those cells that are unable to bind any ligand undergo death by neglect. 1 The developing thymocyte has a window of opportunity during which to sample a variety of ligand/MHC complexes and receive a positively selecting signal before it undergoes programed cell death, but the signals maintaining thymocyte viability and the pathways that control cell survival or death in response to these interactions are not well understood.
Mammalian cells, including thymocytes, have two distinct, albeit ultimately converging, pathways of apoptosis: the 'extrinsic' ('death receptor'-controlled) pathway and the 'intrinsic' (also called 'mitochondrial' or 'Bcl-2-regulated') pathway. 2 The 'extrinsic' pathway is activated by certain members of the TNF family of ligands that bind to the so-called 'death receptors' (members of the TNF receptor family with an intracellular 'death domain') on the cell surface, triggering a cascade of intracellular events that result in cell death. 2 Conversely, the 'intrinsic' apoptotic pathway is regulated by the balance between pro-and anti-apoptotic members of the Bcl-2 family. The pro-survival Bcl-2 family members -Bcl-2, Bcl-x L , Bcl-w, Mcl-1, and A1 -share with each other up to four regions of homology (BH, Bcl-2 homology regions) and are essential for cell survival functioning in a cell type-specific manner. There are two pro-apoptotic subgroups within the Bcl-2 family. Bak, Bax, and possibly also Bok have three BH domains and share surprising structural similarity with their pro-survival relatives, but are essential (in a redundant manner) for downstream events in apoptosis, including mitochondrial outer membrane permeabilization (MOMP) and consequent activation of the caspase cascade. BH3-only proteins, on the other hand, share with each other and the remainder of the Bcl-2 family only the BH3 domain and they are critical for initiation of apoptosis signaling, functioning in a cell death stimulus-and cell type-specific manner. 2 Bcl-2-interacting mediator of cell death (Bim) is a BH3-only Bcl-2 family member that is transcriptionally and/or posttranslationally induced in response to diverse apoptotic stimuli, such as cytokine deprivation or deregulated calcium flux, in a broad range of hematopoeitic, epithelial, and neuronal cell types. [3] [4] [5] Experiments with gene-targeted mice showed that Bim is required for the death of thymocytes in response to growth factor withdrawal, calcium flux, taxol treatment, as well as strong T-cell receptor ligation. 6, 7 Bim is also critical for the apoptosis of peripheral T cells during the contraction phase of an acute immune response. [8] [9] [10] As a potent mediator of cell death, Bim is highly regulated both transcriptionally and post-translationally. Bim is found in three major isoforms that have differing levels of pro-apoptotic activity 4 and are each regulated by various post-translational mechanisms, including phosphorylation, 11 proteosomal degradation, 12 and sequestration to the microtubular dynein motor complex. 13 Although much is known about Bim regulation, questions still remain as to which signaling pathways directly inhibit or promote Bim activity.
Calcium-modulating cyclophilin ligand (CAML) is a transmembrane protein that localizes to the endoplasmic reticulum and small cytoplasmic vesicles. 14, 15 It is ubiquitously expressed and evolutionarily highly conserved in all vertebrates. The exact cellular function of CAML is still unknown, but it has been implicated in diverse cell signaling processes, including calcium signaling, 14 protein trafficking, 16 and chromosome segregation. 17 A CAML conditional knockout mouse in which CAML was deleted relatively late during thymic T-cell development has been described. 18 In that study, using CAML fl/fl mice expressing the jmlckcre transgene, it was observed that CAML-deficient cells experienced increased T-cell receptor stimulation, but that the overall processes of positive and negative selection were intact. 19 Although earlier work suggested that CAML-deficient cells were more susceptible to apoptosis in response to T-cell receptor stimulation compared with control cells, there was no direct evidence that CAML-deficient CD4 þ CD8 þ (double positive, DP) thymocytes exhibit abnormally high rates of apoptosis. Furthermore, it was not examined how CAML may interact with apoptotic signaling pathways.
This study represents the first description of mice in which CAML is deleted during the double negative 2 (DN2)/DN3 stage of development, considerably earlier than the timing of excision reported for the caml fl/fl mice expressing the jmlckcre transgene. In our study, we observed severe reductions in thymocyte subsets, beginning at the DN4 stage of development, which was due to increased apoptosis and did not result from a defect in cell proliferation. The loss of cellularity was dependent on the presence of Bim, but did not require T-cell receptor ligands (peptide/MHC complexes), p53, or Fas signaling.
Results
Loss of CAML early in T-cell development leads to a severe reduction in thymocyte numbers because of abnormally increased apoptosis. To determine the function of CAML in early T-cell development, we crossed mice bearing loxP-flanked Caml alleles (CAML fl/fl ) to cwLckCre mice, which express the Cre recombinase before the DN3 stage of thymocyte development. 20 The cwLckCre-CAML fl/fl mice showed a severe depletion of total thymocytes ( Figure 1a ) in comparison with littermate control CAML fl/fl mice. To investigate whether early T-cell development was impaired by CAML deletion, we examined lineage marker (Mac-1, GR-1, CD8a, TCRb, TCRgd, CD3e, B220, CD19, Ter119, and NK1.1)-negative thymocytes for expression of c-kit and CD25 (Figure 1b ). Quantitation of the earliest subsets of T cells: ETPs (linÀ, c-kit þ , and CD25À), DN2 (linÀ, c-kit þ , and CD25 þ ), and DN3 (linÀ, c-kitÀ, and CD25 þ ) indicated that the numbers of these cells were similar between cwLckCre-CAML fl/fl and control CAML fl/fl mice. However, the numbers of DN4 cells (linÀ, c-kitÀ, CD25À) were reduced by B50% in cwLckCre-CAML fl/fl compared with CAML fl/fl mice ( Figure 1c ). By staining thymocytes for expression of CD4 and CD8, we found that loss of CAML caused an 80-90% reduction in the percentages and total numbers of DP (CD4 þ CD8 þ , DP), CD4 single-positive (CD4 þ CD8À, SP), as well as CD8 SP (CD4ÀCD8 þ ) subsets compared with littermate controls (Figure 1d -e).
In comparison with jmlckcre-CAML fl/fl mice, 19 the cwLckCre-CAML fl/fl mice contained strikingly fewer thymocytes overall and within all subsets from the DN4 to the SP stages of development. For example, CD4 þ CD8 þ DP cells in jmlckcre-CAML fl/fl thymi were reduced 2.2-fold compared with age-matched littermate CAML fl/fl controls, whereas in cwLckCre-CAML fl/fl CD4 þ CD8 þ DP, cells were reduced 8.6-fold compared with CAML fl/fl age-matched littermate controls. In the single-positive populations, jmlckcre-CAML fl/fl thymi had 7.9-fold fewer CD4 þ CD8À SP cells compared with control littermates, whereas the cwLckCre-CAML fl/fl CD4 þ CD8À SP cells had 19.4-fold fewer cells compared with CAML fl/fl thymi. Finally, in the CD4ÀCD8 þ SP population, jmlckcre-CAML fl/fl thymi had 5.2-fold fewer cells when compared with CAML fl/fl age-matched littermate controls, whereas cwLckCre-CAML fl/fl CD4ÀCD8 þ SP cells had 7.3-fold fewer cells compared with CAML fl/fl age-matched littermate controls.
To ensure the efficiency of deletion of the floxed Caml alleles in cwLckCre-CAML fl/fl cells, we used magnetic sorting to enrich for CD4ÀCD8ÀCD44ÀCD25À (DN4) or CD4 þ CD8 þ cells. Western blotting revealed that cwLckCre-CAML fl/fl cells had a 490% reduction in CAML expression compared with CAML fl/fl control cells ( Figure 1f ).
We next examined whether the loss of thymocytes in cwLckCre-CAML fl/fl mice was due to increased cell death or decreased proliferation. We examined the number of apoptotic cells by staining with Annexin V and propidium iodide. A larger percentage of cells in each major thymocyte subset stained positive for Annexin V and propidium iodide in cwLckCre-CAML fl/fl cells compared with CAML fl/fl littermates (Figure 2a ).
As CAML has been implicated as a regulator of the mitotic spindle checkpoint, and CAML-deficient cells were reported to exhibit defects in cellular division, 17 it was important to determine whether CAML is essential for mitosis in thymocytes. To determine whether CAML loss was accompanied by defective proliferation, we injected mice with 2-bromodeoxyuridine (BrdU) and then removed thymi after 90 min. Thymocytes were surface stained with antibodies to CD4 and CD8 to define the four major thymocyte subsets and intracellularly with an antibody to BrdU to measure the rate of incorporation of this thymidine analog into dividing cells. Cells of all thymocyte subsets from cwLckCre-CAML fl/fl showed increased proliferation compared with control CAML fl/fl littermates ( Figure 2b ). Thus, we conclude that loss of CAML early in T-cell development decreases the ability of pre-T cells to survive, resulting in reduced thymic numbers beginning at the DN4 stage of development (and possibly a compensatory increase in cell cycling). In addition, the increase in proliferation in DN and DP subsets indicates that cwLckCre-CAML fl/fl cells have intact pre-TCR signaling and that lack of a signal through the pre-TCR cannot account for the loss of the DP cwLckCre-CAML fl/fl cells.
CAML is critical for thymocyte survival after exposure to a specific subset of apoptotic stimuli. To further investigate the differences in survival between control and CAMLdeficient thymocytes, we subjected cwLckCre-CAML fl/fl and control CAML fl/fl cells to a variety of apoptotic stimuli. We observed that in response to treatment with phorbol ester, ionomycin, thapsigargin, staurosporine, dexamethasone, or hydrogen peroxide, cell death was comparable between control and CAML-deficient cells ( Figure 3 ). In contrast, cwLckCre-CAML fl/fl thymocytes were significantly more sensitive than control cells to certain other stimuli, including cytokine deprivation, treatment with etoposide (even 100-fold lower concentrations), or stimulation of the death receptor Fas (Figure 3 ).
P53 is not required for the enhanced apoptosis caused by CAML deficiency. Cell death after treatment with the topo-II inhibitor etoposide is dependent on p53 and its transcriptional induction of the pro-apoptotic BH3-only protein Puma. 21 To investigate whether the enhanced apoptosis in CAML-deficient thymocytes might be due to abnormally increased activation of p53, we crossed cwLckCre-CAML fl/fl mice to p53 À/À animals. However, cwLckCre-CAML fl/fl ;p53 À/À mice showed no increase in thymocyte numbers compared with cwLckCre-CAML fl/fl controls (Supplementary Figure S1 ), indicating that p53 is not required for CAML-deficiency-induced thymocyte death in vivo. Fas is not required for the enhanced apoptosis caused by CAML deficiency. As CAML-deficient thymocytes exhibited abnormally increased sensitivity to Fas-induced apoptosis, we explored whether Fas is critical for the abnormal thymocyte reduction caused by loss of CAML. Fas-mediated apoptosis was dependent on caspase activity, as treatment with ZVAD rescued both cwLckCre-CAML fl/fl and CAML fl/fl cells from this death (Figure 4a and b). Next, we analyzed Fas surface expression on cwLckCre-CAML fl/fl and CAML fl/fl littermates and found that the levels were comparable (Figure 4c ). The increased sensitivity to Fas stimulation was unexpected, as evidence suggests that Fas does not have a function in the developmentally programed death of thymocytes. 22 Thus, we considered two possible scenarios: one in which the Fas receptor had been inappropriately activated in the absence of CAML, and another in which the Fas sensitivity of cwLckCre-CAML fl/fl cells reflected a deficiency of a central survival pathway within the cells.
To distinguish between these two possibilities, cwLckCre-CAML fl/fl mice were crossed to Fas-deficient Fas lpr/lpr mice. 23 Interestingly, loss of Fas did not cause a rescue of thymic cellularity in cwLckCre-CAML fl/fl ;Fas lpr/lpr mice (Figure 4d , compare third and fourth columns). This supports the notion that Fas does not mediate the abnormally enhanced in vivo death of cwLckCre-CAML fl/fl thymocytes, but instead suggests that these cells have a more general aberration in survival that renders them more sensitive to Fas stimulation in vitro plus other death stimuli.
Others have used cwLckCre mice for multiple analyses and have not reported non-specific toxicity because of thymic Cre expression. Nonetheless, to rule out a possible cytotoxic effect 24 of Cre in our mice, we also analyzed cwLckCre-CAML þ / þ mice for overall thymic numbers and sensitivity to Fas-mediated apoptosis. As seen in Figure 4e -f, CAML loss, and not the cre transgene, was responsible for the loss of thymic cellularity and the abnormally increased sensitivity to Fas-mediated apoptosis.
Loss of Bim partially rescues thymocyte survival in CAML-deficient mice. The pro-apoptotic BH3-only protein Bim has been shown to be essential for the initiation of several pathways that induce apoptosis in thymocytes, 7 including cytokine withdrawal and calcium flux. We, therefore, crossed bim À/À mice with the conditional CAML knockout mice to test whether Bim is required for the reduction in cell numbers observed in cwLckCre-CAML fl/fl thymi. Interestingly, cwLckCre-CAML fl/fl ;bim À/À thymi showed a significant increase in the number of DP thymocytes. Although cwLckCre-CAML fl/fl mice had only 13% of the numbers of DP cells compared with CAML fl/fl animals, cwLckCre-CAML fl/fl ; bim À/À mice had 46% of the numbers of these thymocytes compared with CAML fl/fl ;bim À/À littermate controls (Figure 5a and b), indicating that Bim must contribute to the enhanced death of CAML-deficient thymocytes. Given that Bim appeared responsible for a significant portion of thymocyte death elicited by loss of CAML, we examined whether Bim expression is abnormal in CAMLdeficient cells. We first evaluated total cellular levels of Bim in CD4 þ CD8 þ DP cells and found it to be comparable or slightly diminished in the absence of CAML when compared with control cells (Figure 5c ). In addition to total cellular levels, Bim is also regulated by intracellular localization, 13 including subcellular localization to the mitochondrial outer membrane, and by association with pro-survival Bcl-2 family members. 25 We found that in CAML-deficient cells, Bim was reproducibly increased in the pellet fraction of cells lysed with 1% Triton X-100 (TX-100) and modestly increased in isolated mitochondria (Figure 5d ), indicating that loss of CAML causes mislocalization of Bim.
T-cell receptor interaction with peptide/MHC complexes is not required for the enhanced apoptosis of CAMLdeficient thymocytes. Bim is essential for thymocyte apoptosis caused by strong TCR stimulation and critical for negative selection of autoreactive thymocytes. As we earlier reported that jmLckCre-CAML fl/fl T lymphocytes exhibit abnormally increased T-cell receptor stimulation, 19 it appeared likely that augmented TCR signaling might be responsible for their abnormally increased apoptosis. Others have shown the function of TCR signaling in DP thymocyte killing in MINK-deficient mice by removing class I and II major histocompatibility antigens. 26 In a similar manner, we examined whether MHC/T-cell receptor interaction was required for the enhanced death of cwLckCre-CAML fl/fl thymocytes by crossing cwLckCre-CAML fl/fl mice with MHC class II-deficient (Ab 0 ) 27 and MHC class I-deficient (b2-microglobulin À/À ) mice. 28 In contrast to thymocytes lacking MINK in which MHC deficiency rescued normal DP development, loss of MHC did not rescue the survival of DP thymocytes in cwLckCre-CAML fl/fl mice (Figure 6a  and b ). This indicates that T-cell receptor/MHC interactions are not required for the abnormally increased death of CAML-deficient pre-T cells.
Abnormally elevated levels of reactive oxygen species in cwLckCre-CAML fl/fl mice. Reactive oxygen species (ROS) have been reported to induce Bim-dependent death in T cells. 29 As loss of Bim increases thymocyte numbers in the absence of CAML, we compared ROS levels between CAML-deficient and control thymocytes by intracellular staining with DCFDA. cwLckCre-CAML fl/fl CD4 þ CD8 þ thymocytes were reproducibly found to have elevated ROS levels (Figure 7a and b) in comparison with cells from littermate control animals. ROS in cwLckCre-CAML fl/fl cells appeared to be of mitochondrial origin, as verified by staining with the mitochondrial-localizing ROS dye Mitosox 30 (Figure 7c ). To ensure that DCFDA staining was indeed labeling ROS, we administered the antioxidant N-acetyl-cysteine (NAC) to mice to reduce ROS, removed thymi, and then stained the cells with DCFDA. As expected, treatment of mice with NAC reduced the high ROS levels found in thymocytes from CAML-deficient mice (Figure 7d ). In addition, we treated cells in vitro with inhibitors of ROS generation: diphenyleneiodonium chloride (DPI), an inhibitor of NADPH oxidase, and carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), a mild decoupling agent that reduces mitochondrial ROS when used at low concentrations. 31 Figure 7 cwLckCre-CAML fl/fl thymocytes contain abnormally increased levels of ROS. (a) Freshly isolated thymocytes from cwLckCre-CAML fl/fl mice and littermate controls were stained with anti-CD4 plus anti-CD8 antibodies and the ROS-specific dye 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate, di(acetoxymethyl ester) (DCFDA). Histograms depicting ROS levels in each CD4/CD8 subset are shown. One representative of three independent experiments is shown. (b) Quantitation of the ROS staining in the CD4 þ CD8 þ thymic sub-population. The average of three independent experiments is shown. (c) Freshly isolated thymocytes from cwLckCre-CAML fl/fl mice and littermate controls were stained with anti-CD4 plus anti-CD8 antibodies and the mitochondrial ROS-specific dye, Mitosox. Levels of mitochondrial ROS found in CD4ÀCD8À and CD4 þ CD8 þ thymic sub-populations are shown. One representative of three independent experiments is shown. (d) Mice of the indicated genotypes were fed NAC in their water at 10 mg/ml for 2 weeks. Thymocytes were removed and examined for levels of ROS through DCFDA staining. (e) Thymocytes were treated for 2 h with DPI plus FCCP and were then stained with DCFDA to determine percent inhibition of ROS levels. One representative experiment of two independent experiments is shown. We found that both reagents reduced ROS levels to a greater extent in the cwLckCre-CAML fl/fl cells than within CAML fl/fl cells (Figure 7e ).
Abnormally increased ROS levels could be a cause of death or simply a downstream consequence of programmed cell death. To distinguish between these possibilities, we (Figure 7f ), indicating that ROS are required for the abnormally increased sensitivity of CAML-deficient thymocytes to Fas-mediated death. To determine whether NAC could also diminish the sensitivity of cwLckCre-CAML fl/fl cells to other apoptotic stimuli, we added NAC to cells immediately after isolation from the thymus and cultured them for 6, 12, and 24 h in simple medium (to mimic cytokine deprivation). Remarkably, NAC was able to augment the viability of cwLckCre-CAML fl/fl thymocytes cultured without cytokines at each time point (Figure7g).
Discussion
Here, we establish an essential function for CAML in maintaining the survival of developing thymocytes. CAML does not protect thymocytes indiscriminately against all cytotoxic insults; rather, it protects them from Fas stimulation, etoposide treatment, and cytokine deprivation, but not from treatment with phorbol ester, ionomycin, thapsigargin, staurosporine, dexamethasone, or hydrogen peroxide. Our data suggest that CAML does not prevent TCR or p53mediated death, but instead protects cells from Bim-induced death, most likely by blocking the production of ROS.
Although earlier studies suggested a connection between CAML and cell survival, the function of CAML in this process has been a mystery. CAML interacts with K7, 32 a viral protein important for maintaining cell viability during infection, and E3-6.7K, a TACI viral homolog 33 that was shown to increase survival of cells exposed to extrinsic apoptotic stimuli. 34 What is the molecular mechanism by which CAML potentiates thymocyte survival? Several important steps of this process are revealed by this work. First, CAML-deficient cells have enhanced levels of ROS. ROS have been implicated in many types of cell death, including activationinduced apoptosis of T cells 35 and increasing the susceptibility of cells to extrinsic death stimuli. 36 The decreased redox potential of CAML-deficient cells may render them more susceptible to Fas ligation and cytokine deprivation, as evidenced by the ability of the antioxidant NAC to reduce the susceptibility of CAML-deficient cells to Fas stimulation and cytokine deprivation. The ability of NAC to inhibit this enhanced death also provides evidence that the high ROS levels are not a consequence of cellular demolition, but rather that the ROS generated in CAML-deficient cells contribute to increased apoptosis signaling.
Second, the death of thymocytes lacking CAML requires the pro-apoptotic BH3-only Bcl-2 family member Bim. Bim has been shown to be critical for negative selection of autoreactive thymocytes and immature B cells, and for cytokine-withdrawal-induced death of a broad range of cell types, 6 and Bim is induced by TCR or BCR signaling 7, 37 and ROS. 38 In contrast to our earlier study of more mature single-positive thymocytes that showed abnormally augmented TCR signaling as a consequence of CAML deficiency, 19 we did not find evidence for TCR signal dependence of the enhanced death of CAML-deficient thymocytes, although Bim is clearly required for the excess thymocyte death. Ca 2 þ signaling also regulates Bim, 39 but we do not suspect that CAMLdeficient cells have abnormal Ca 2 þ influx, because there was no defect in pro-T-cell proliferation, which also requires Ca 2 þ signaling. Moreover, CAML-deficient thymocytes had a normal content of intracellular-free Ca 2 þ (data not shown). We examined how Bim might be activated to promote the destruction of CAML-deficient cells and found that Bim was neither increased at the protein level, nor did it show altered migration on SDS-PAGE, which would suggest a difference in phosphorylation. However, in the absence of CAML, Bim was localized more strongly to the pellet fraction of cells lysed with 1% Triton lysis buffer. Although we have not conclusively shown that CAML directly alters Bim localization, in light of CAML's function in trafficking the EGFR, 16 it is tempting to speculate that CAML may have a function in preventing Bim from moving to the mitochondria.
Precisely, how CAML acts to block ROS induction and Bim activation is not yet clear. However, CAML has earlier been shown to interact with several protein kinases, including EGFR, 16 Lck, 19 and Hck (unpublished data). Modulation of the activity or intracellular location of one or more such kinases may, therefore, constitute one of the critical functions of CAML. Indeed, in preliminary studies, we have identified a physical interaction between the serine-threonine kinase Raf-1 and CAML (Supplementary Figure S2) . Notably, Raf has been implicated in signaling pathways that inhibit apoptosis, 40 and dominant-negative mutants of Raf block thymocyte development. 41 Moreover, Raf-1 was shown to regulate cellular levels of ROS and is thought to thereby control cellular responses to cytokine withdrawal. 31 Importantly, for this study, it has been shown that pharmacological blockade of Raf signaling kills certain tumor cells through Bim induction. 42 Raf-1 has also been reported to protect cells from external apoptotic stimuli, including Fas ligation, 43 a stimulus to which CAML-deficient thymocytes are extremely sensitive. It is, therefore, tempting to speculate that CAML might regulate the survival function of Raf-1. Future studies will be required to determine whether the Raf-CAML interaction participates in the pro-survival function of CAML in this cell type.
Materials and Methods
Mice. All experiments used 3-6-week-old gender-matched littermate controls that were on a mixed C57BL/6x129/SvJ background. Dr. David Tran developed CAML fl/fl mice, 19 which were generated using 129/SvJ ES cells. cwlckcre (C57BL/6NTac-TgN(Lck-Cre) stock number: 004197) mice were purchased from Taconic (Hudson, NY, USA). Bim-deficient (B6.129S1-Bcl2l11 tm1.1Ast /J stock number: 004525) and LPR (B6.MRL-Fas lpr /J stock number: 000482) mice (both backcrossed onto a C57BL/6 background for 420 generations) were purchased from Jackson Labs (Bar Harbor, ME, USA). p53-deficient mice were a gift from Dr. Jan VanDeurson. MHC-deficient (b2-microglobulinÀ/À and class II MHCÀ/À) mice were a gift from Dr. Chella David. All animal experiments were performed according to IACUC guidelines and were approved by the IACUC.
Reagents. Ionomycin (407952) and thapsigargin (586005) were purchased from Calbiochem (Gibbstown, NJ, USA). PMA (13139-019) was purchased from Gibco (Carlsbad, CA, USA). Etoposide (E1383), hydrogen peroxide (349887), DPI(D2926), carbonyl cyanide-p-trifluoromethoxyphenyl-hydrazone (FCCP C2920), and NAC (A9165) were purchased from Sigma (St. Louis, MO, USA). Jo2 (554254) hamster anti-mouse Fas antibody was purchased from BD Pharmingen (Franklin Lakes, NJ, USA).
